Benefit and risk associated with interleukin-6 receptor inhibitor administration during severe COVID-19: a retrospective multicentric study

  1. Charlène Lefèvre
  2. Théo Funck-Brentano
  3. Marine Cachanado
  4. Alexia Plocque
  5. Maëlle Youinou
  6. Audrey Fels
  7. Frédéric Pène
  8. Laurent Savale
  9. David Montani
  10. Olivier Voisin
  11. Flore Bintein
  12. Lucille Wildenberg
  13. Axel Philippe
  14. Stéphane Legriel
  15. Nicolas Roche
  16. Pierre-Régis Burgel
  17. Marc Tran
  18. Nicolas Noël
  19. Christophe Baillard
  20. Jacques Duranteau
  21. Gilles Chatellier
  22. Francois Philippart
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1038/s41598-026-36864-w
  2. Version published to 10.21203/rs.3.rs-6785789/v1 on Research Square